Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Similares en SciELO
Compartir
Archivos de cardiología de México
versión On-line ISSN 1665-1731versión impresa ISSN 1405-9940
Resumen
ARELLANO-BUENDIA, Abraham S. et al. Molecular mechanisms of the beneficial effects of allicin on cardiovascular disease. Arch. Cardiol. Méx. [online]. 2022, vol.92, n.3, pp.362-370. Epub 08-Ago-2022. ISSN 1665-1731. https://doi.org/10.24875/acm.21000196.
Cardiovascular diseases (CVD) include a group of diseases whose common denominator is the affection of the blood vessels, heart, and heart rate. The treatment of CVD represents high costs to the health systems and is focused on the control of risk factors. Despite the existence of a great variety of treatments of the CVD, these continue as the main cause of mortality mainly due to the multifactorial origin, and therefore more than one drug is required. In this context, allicin, a compound derived from garlic, has shown regulate the expression of signaling pathways and risk factors associated with the progression of CVD. Therefore, the objective of this work is to review the cellular and molecular mechanisms through which allicin exert its therapeutic effects and to describe the scientific evidences why allicin represents a potential candidate to assist in the treatment of CVD.
Palabras llave : Allicin; Cardiovascular disease; Risk factors; Molecular mechanisms.